Deals of the day-Mergers and acquisitions
Oct 4 (Reuters) -The following bids, mergers, acquisitions and disposals were reported by 0930 GMT on Friday:
** Italian pharma group Recordati RECI.MI said it would buy from Sanofi SASY.PA the global rights to a drug used to treat cold agglutinin disease, a rare autoimmune disorder, for $825 million, sending both stocks up in early trade. nL1N3LG05Q
** U.S. bank JPMorgan Chase & Co JPM.N has become a substantial shareholder in Star Entertainment SGR.AX, an exchange filing showed, as shares of the embattled Australian casino operator have fallen sharply in last few years amid liquidity issues. nL4N3LG00T
** Private equity firm Apollo Global Management APO.N is in talks to acquire Barnes Group B.N, a manufacturer of aerospace components with a market value of about $2 billion, people familiar with the matter said. nL4N3LF16P
** U.S. utility firm Talen Energy TLN.O said it has bought TeraWulf's WULF.O minority stake in a 200-megawatt (MW) bitcoin mining facility in Pennsylvania. nL4N3LF1D7
** Thomson Reuters TRI.TO, TRI.N said it was selling its FindLaw business to Internet Brands. nL4N3LF191
(Compiled by Rajarshi Roy and Neil J Kanatt in Bengaluru)
</body></html>Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
